Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 6.30
-0.04 (-0.63%)
Sep 15, 2025, 9:35 AM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €177.52 million as of September 12, 2025. Its market cap has increased by 5.67% in one year.
Market Cap
177.52M
Enterprise Value
155.19M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.30
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 177.52M, a decrease of -27.45%. That is a compound annual growth rate of -5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 177.52M | -3.06% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 40.07B |
| UCB SA | 39.86B |
| Financière de Tubize | 7.57B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 341.83M |
| Onward Medical | 229.03M |
| Nyxoah | 180.25M |
| Sequana Medical NV | 64.63M |